Abstract:Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and causes about one million deaths annually [1, 2], however, most patients are diagnosed at an advanced stage, Transcatheter arterial chemoembolization (TACE) is one of the most common and effective palliative treatments and meta-analysis of a randomized controlled trial has shown that survival is improved after treatment [3]. Despite documented survival benefits, TACE can also induce the up-regulation of proangiogenic and growth factors, which might contribute to accelerate the progression of HCC in patients with incomplete response. Therefore, it is clinically important to analyse the therapeutic effect of TACE as soon as possible [4]. Conventional imaging modalities, such as computed tomography (CT) or magnetic resonance imaging (MRI), cannot satisfy clinicians in that context, because treatment evaluation by these anatomical imaging modalities requires a sufficient period of time in order to confirm tumor shrinkage. Additionally, the ability of contrast CT to determine tumor viability after TACE is limited, because the retained hyperattenuating lipiodol makes it difficult to detect contrast enhancement within a viable tumor. The 18F-fluoro-2-deoxy-D-glucose positron-emission-tomography (18F-FDG PET) is a functional imaging tool that provides metabolic information of the lesion. It is effective for diagnosis, monitoring treatment and detection of recurrent tumors of various cancers because of its high sensitivity and specificity [5]. In contrast to morphological imaging techniques such as CT, the 18F-FDG PET evaluates tumor viability based on glucose metabolism; it is not influenced by tumor morphology or lipiodol deposition. Therefore, as several investigators have previously reported 18F-FDG PET might be useful for monitoring response and for being a guide in following treatment [6]. Our present report and a previous study of ours have shown that increased 18F-FDG uptake was not correlated with lipiodol dense distribution [7]. Researchers have also found that 18FDG PET was valuable to reveal recurrent tumor or residual tumor in HCC patients after TACE [8]. Jinpeng Li1 MD, Wenbo Shao1MD, PhD, Jinlong Song1 MD, Congcong Shi2, Hua Chen1 MD, Ning Cong1 MD. (Jinpeng Li and Wenbo Shao contributed equally to this study)

Study on Arterial Infusion of NaHCO_(3) and Verapamil to Improve Effects of Transcatheter Arterial Embolization (TAE) in Hepatocarcinoma by Color Dopple Ultrusonography

Assessment of Hepatocellular Carcinoma Undergoing Trans-Catheter Arterial Chemoembolization with Functional Magnetic Resonance Imaging

Are Autologous Bone Marrow Stem Cell Transplantation and Transcatheter Arterial Embolization the Best Choices for Patients with Hepatocellular Carcinoma and Hepatic Dysfunction? Report of a Case

Cinnamic Acid Derivatives Enhance the Efficacy of Transarterial Embolization in a Rat Model of Hepatocellular Carcinoma

Caco3-Encapuslated Microspheres For Enhanced Transhepatic Arterial Embolization Treatment Of Hepatocellular Carcinoma

The Therapeutic Effect of Transcatheter Arterial Chemoembolization Combined with Percutaneous Ethanol Injection for Large Hepatocellular Carcinoma

Hepatic Arterial Chemoembolization Combined with DSA-guided Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma:Evaluation of the Therapeutic Effect

CaCO 3 ‐Encapuslated Microspheres for Enhanced Transhepatic Arterial Embolization Treatment of Hepatocellular Carcinoma

Clinical Efficacy of Transcatheter Arterial Chemoembolization Combined With Percutaneous Microwave Coagulation Therapy for Advanced Hepatocellular Carcinoma

The inhibiting effect of alpha-based TARE on embolized vessels and neovascularization

Elimination Rate Of Tumor'S Blood Supply, Tumor Necrosis Rate And Adverse Reactions In Advanced Hepatocellular Carcinoma Treated By Transcatheter Arterial Chemoembolization With Radiofrequency Ablation

Application of Transcatheter Hepatic Arterial Chemoembolization Combined with Continues Intravenous Injection in the Treatment of Liver Metastases from Gastric Carcinoma

[Clinical Effect of Transcatheter Arterial Chemoembolization Combined with High Intensity Focused Ultrasound Ablation in Treatment of Large Hepatocellular Carcinoma].

Investigation of Increased Efficacy of Trans-Arterial Infusion of HaHCO_3 and Verapamil on Solid Malignant Tumors in Interventional Chemotherapy

Increased Effects of Verapamil Combined with NaHCO_3 by Aterial Infusion in Patients with Solid Maligant Tumors

Transcatheter Arterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy Versus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

Clinical Investigation of Chemoembolization of Hepatic Artery Combined with Portal Venous in Treating the Moderate and Advanced Hepatic Carcinomas

Advanced Imaging Techniques in the Therapeutic Response of Transarterial Chemoembolization for Hepatocellular Carcinoma

The Therapeutic Effect of Transcatheter Arterial Thromboembolization of Hepatocellular Carcinoma As for Residual Viable Tumors Related to Lipoidal Density Areas and Detected by (18)F-FDG PET/CT and CT.

Clinical results of treating metaphase and advanced hepatic carcinoma with intra-hepatic artery chemotherapy and embolizing therapy

Efficacy and safety of ultrasound-guided radiofrequency ablation combined with transhepatic artery embolization chemotherapy for hepatocellular carcinoma: A meta-analysis